Adam Felman Author Pecci-Lloret MP et al
3-Month GLP-1 Weight Loss Program Kickstart your wellness journey with our physician-supervised Semaglutide weight loss program , designed to help you achieve safe, steady, and sustainable results
Prescription medications used to treat attention deficit hyperactivity disorders include stimulants such as amphetamine/dextroamphetamine (Adderall), methylphenidate (Ritalin, Concerta), lisdexamfetamine ( Vyvanse ), and dextroamphetamine (Dexedrine Spansule)
Microbiome changes Rapid weight loss and metabolic changes can alter the vaginal microbiome, potentially increasing susceptibility to yeast infections and bacterial vaginosis
Many people feel fine at first, then hunger surges later In the STEP 1 extension, participants regained about two thirds of prior weight loss in the year after stopping A 2026 BMJ meta-analysis estimated average regain of roughly 0.4 kg per month after stopping weight-loss medications, with return toward baseline projected within 1.5 to 1.7 years The same meta-analysis found no evidence that more intense behavioural support during treatment meaningfully changed the rate of regain after stopping Weight regain is often accompanied by reversal of cardiometabolic improvements, not just scale change Summary Stopping semaglutide should be understood as a biology handoff
Readers tracking application progress can follow our generic semaglutide tracker or use the insurance coverage checker for plan-specific questions, and additional context is available in the FAQ